Brian Stuglik
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Mr. Brian M.
Stuglik is an Independent Director at Puma Biotechnology, Inc., an Independent Director at Oncopeptides AB, a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology, Inc. and a Member at International Association for the Study of Lung Cancer.
He is on the Board of Directors at Puma Biotechnology, Inc., Oncopeptides AB and Verastem, Inc. Mr. Stuglik was previously employed as a Member by Proventus Health Solutions LLC and a Chief Marketing Officer-Oncology Division & VP by Eli Lilly & Co. He received his undergraduate degree from Purdue University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 113’858 ( 0.22% ) | 816 362 $ | 31.05.2026 | |
VERASTEM, INC. 0.22% | 21.05.2026 | 137’147 ( 0.22% ) | 593 847 $ | 31.05.2026 |
ONCOPEPTIDES AB 0.04% | 31.12.2024 | 154’828 ( 0.04% ) | 30 351 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VERASTEM, INC. | Direktor/Vorstandsmitglied | 02.09.2017 |
| ONCOPEPTIDES AB | Direktor/Vorstandsmitglied | 17.05.2018 |
| PUMA BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 05.07.2020 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
International Association for the Study of Lung Cancer
International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a global organization dedicated to the research and study of lung cancer. The company is based in Aurora, CO. With a focus on advancing the understanding and treatment of lung cancer, the IASLC brings together researchers, healthcare professionals, and advocates from around the world. Through collaboration and education, the organization aims to improve patient outcomes and reduce the global burden of lung cancer. | Corporate Officer/Principal | - |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.12.2015 |
Proventus Health Solutions LLC
Proventus Health Solutions LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical companies in oncology drug development process | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
International Association for the Study of Lung Cancer
International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a global organization dedicated to the research and study of lung cancer. The company is based in Aurora, CO. With a focus on advancing the understanding and treatment of lung cancer, the IASLC brings together researchers, healthcare professionals, and advocates from around the world. Through collaboration and education, the organization aims to improve patient outcomes and reduce the global burden of lung cancer. | Commercial Services |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Puma Biotechnology, Inc.
Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Proventus Health Solutions LLC
Proventus Health Solutions LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical companies in oncology drug development process | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen